Polomar Health Services, Inc. (PMHS) stock
PMHSOTCPharmaceutical PreparationsFiscal year ends December 31
$0.12−0.01 (-4.00%)
Close on Oct 19, 2026Market cap $3.37MP/E –Yield –
Polomar Health Services operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Polomar Health Services's operating income for the twelve months ending Jun 30, 2026 was -$9.36M. For fiscal 2025 it was -$10.55M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$10.55M | – |
| FY2024 | Dec 31, 2024 | -$1.30M | – |
| FY2023 | Dec 31, 2023 | -$440.83K | – |
| FY2022 | Dec 31, 2022 | -$181.45K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $218.38K | – |
| Q1 FY2026 | Mar 31, 2026 | -$6.90K | – |
| Q4 FY2025 | Dec 31, 2025 | -$8.94M | – |
| Q3 FY2025 | Sep 30, 2025 | -$628.81K | – |
| Q2 FY2025 | Jun 30, 2025 | -$563.33K | – |
| Q1 FY2025 | Mar 31, 2025 | -$415.41K | – |
| Q4 FY2024 | Dec 31, 2024 | -$689.11K | – |
| Q3 FY2024 | Sep 30, 2024 | -$259.17K | – |
| Q2 FY2024 | Jun 30, 2024 | -$190.74K | – |
| Q1 FY2024 | Mar 31, 2024 | -$160.47K | – |
| Q4 FY2023 | Dec 31, 2023 | -$94.54K | – |
| Q3 FY2023 | Sep 30, 2023 | -$134.68K | – |
| Q2 FY2023 | Jun 30, 2023 | -$90.96K | – |
| Q1 FY2023 | Mar 31, 2023 | -$89.81K | – |
| Q4 FY2022 | Dec 31, 2022 | -$151.98K | – |
| Q3 FY2022 | Sep 30, 2022 | -$13.52K | – |
| Q2 FY2022 | Jun 30, 2022 | -$13.71K | – |
See a number that looks wrong?